Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201109179 Principal Investigator: Van Tine, Brian
Title: Determination of Tumor Response Rate by RECIST and FDG-PET Criteria to Dacarbazine in Metastatic Soft Tissue and Bone Sarcoma
Description: This study is for patients who have an advanced form of soft tissue or bone sarcoma that has spread to other parts of the body. This study will evaluate the response to treatment and side effects of dacarbazine. ...MORE
___________________________________________________________________________________________________
 Number: 201211010 Principal Investigator: Van Tine, Brian
Title: Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors
Description: The purpose of this research study is to determine how well malignant peripheral nerve sheath tumors respond (experience tumor shrinkage or lack of further tumor growth) to treatment with everolimus in combination with bevacizumab....MORE
___________________________________________________________________________________________________
 Number: 201208085 Principal Investigator: Van Tine, Brian
Title: A Phase IB/II Study of Gemcitabine and Docetaxel in Combination with Pazopanib (gem/doce/pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Description: The purpose of this study is to see the effects, good and/or bad, of the drug combination of gemcitabine, docetaxel and pazopanib on patients and their sarcoma....MORE
___________________________________________________________________________________________________
 Number: CALGB A091105 Principal Investigator: Van Tine, Brian
Title: A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)
Description: The purpose of this study is to compare the effects, good and/or bad, of the drug sorafenib might have on the growth of desmoid tumors....MORE
___________________________________________________________________________________________________
 Number: CALGB A091102 Principal Investigator: Van Tine, Brian
Title: Phase II Study of MLN8237 in Advanced/Metastatic Sarcoma
Description: The purpose of this study is to see the effects, good and/or bad, of the investigational drug MLN8237 on patients and their sarcoma....MORE
___________________________________________________________________________________________________
 Number: 201202120 Principal Investigator: Van Tine, Brian
Title: A prospective, multicenter, randomized, open-label, active-controlled, two-parallel groups, phase 3 study to compare the efficacy and safety of masitinib to sunitinib in patients with gastrointestinal stromal tumor resistant to imatinib
Description: The purpose of this research study is to compare the efficacy and safety of a drug called masitinib to those of a standard treatment for GIST called sunitinib....MORE
___________________________________________________________________________________________________
 Number: 201105233 Principal Investigator: Adkins, Douglas
Title: A Registry of Caris Life Sciences® Molecular Intelligence™ Service (Biomarker Assessment Results) Intended for for Correlation with Cancer Clinical Outcomes
Description: The purpose of this research is to create a repository for storing medical information so that it is available to investigators for use in future research studies....MORE
___________________________________________________________________________________________________